$DARA Headlines Wednesday’s biggest gaining an
Post# of 89138

Wednesday’s biggest gaining and declining stocks 4:46 p.m. Dec. 29, 2010 - Kate Gibson
Orphan Designation A Game-Changer For DARA 10:00 a.m. Dec. 16, 2013 - Seeking Alpha
10-Q: DARA BIOSCIENCES, INC. 4:36 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
A Look Back At Biotech Short Picks 1:18 p.m. Oct. 31, 2013 - Seeking Alpha
DARA Raises Cash, Expands Sales Force 10:18 a.m. Oct. 28, 2013 - Seeking Alpha
Patience Required For Dara Bio Investment 12:26 p.m. Aug. 15, 2013 - Seeking Alpha
5 Bullish Biotech Charts 8:44 a.m. July 15, 2013 - InvestorPlace.com
10-Q: DARA BIOSCIENCES, INC. 3:06 p.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
Helsinn, DARA Announce U.S. Launch of Gelclair 6:37 a.m. April 22, 2013 - benzinga.com
Dara Biosciences: Don't Believe The Hype Surrounding This Biopharma 6:34 a.m. April 11, 2013 - Seeking Alpha
DARA Bio: A Vastly Undervalued Emerging Story 9:17 a.m. April 10, 2013 - Seeking Alpha
DARA Biosciences Announces Distribution Deal for Gelclair(R), Soltamox(R) 6:04 a.m. April 3, 2013 - benzinga.com
The Week Ahead Could Be Pivotal For These Small Cap Companies' Stocks 7:52 a.m. April 2, 2013 - Seeking Alpha
10-K: DARA BIOSCIENCES, INC. 3:15 p.m. March 28, 2013 - Edgar Online - (EDG = 10Q, 10K)
Nuvilex: A Penny Stock That Could Be A Disease-Fighting Game Changer 9:01 a.m. March 22, 2013 - Seeking Alpha
Biotech Stocks With Recent Developments: 3 To Consider, 1 To Avoid 5:28 a.m. March 6, 2013 - Seeking Alpha
Upcoming Catalysts For These BioPharmas Provide Potential Upside 8:05 a.m. Feb. 20, 2013 - Seeking Alpha
Dara BioSciences: A Catalyst Primer 10:38 a.m. Feb. 5, 2013 - Seeking Alpha
Imminent Catalysts Should Keep Investor Interest Alive For Dara BioSciences 7:20 a.m. Feb. 5, 2013 - Seeking Alpha
Meetings With Management: JPM Healthcare And The Biotech Showcase 3:26 p.m. Jan. 11, 2013 - Seeking Alpha
Quest Diagnostics Unafraid of the SCOTUS, Stryker Investigated in Poland: Healthcare Business Recap 2:57 p.m. Dec. 31, 2012 - Wall St. Cheat Sheet
DARA BioSciences Completes Breast Cancer CAPTURE Registry 8:32 a.m. Dec. 3, 2013 - Marketwire
DARA Reports Third Quarter 2013 Financial Results and Highlights Commercial Momentum on Synergistic Oncology Supportive Care Product Portfolio 8:05 a.m. Nov. 14, 2013 - Marketwire
NASDAQ Grants DARA BioSciences 180-Day Extension to Regain Compliance With Bid Price Requirement 1:18 p.m. Nov. 12, 2013 - Marketwire
DARA BioSciences to Announce Third Quarter 2013 Financial Results and Corporate Business Update on November 14, 2013 8:05 a.m. Nov. 12, 2013 - Marketwire
DARA BioSciences Announces Sales Force Expansion and Agreement With Mission Pharmacal in the Oncology Market 7:02 a.m. Oct. 28, 2013 - Marketwire
DARA BioSciences Announces Registered Direct Offering of $2.55 Million 7:05 a.m. Oct. 22, 2013 - Marketwire
Gelclair(R) Placed on Memorial Sloan-Kettering Cancer Center Formulary as Exclusive Product to Treat Patients With Oral Mucositis 7:02 a.m. Oct. 17, 2013 - Marketwire
Wrentham Breast Cancer Survivor and Owner of Norton Hair Salon Appears on The Balancing Act(R) Airing on Lifetime Television 7:00 a.m. Oct. 7, 2013 - BusinessWire
DARA BioSciences Sponsors Educational Programming on The Balancing Act(R) in Support of Breast Cancer Awareness Month 7:00 a.m. Oct. 4, 2013 - BusinessWire
Watch Exclusive CEO Interviews on Equities.com: ATOS, DARA, EDAP, IMNP, SBOTF 7:00 a.m. Sept. 25, 2013 - GlobeNewswire
DARA BioSciences Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10, 2013 8:03 a.m. Sept. 5, 2013 - Marketwire
DARA BioSciences Announces At-the-Market Common Stock Sales Program 3:28 p.m. Aug. 19, 2013 - Marketwire
DARA Reports Second Quarter 2013 Financial Results and Operational Overview 1:01 p.m. Aug. 14, 2013 - Marketwire
Tennessee Oncology Announces Participation in DARA BioSciences Breast Cancer CAPTURE Registry 7:00 a.m. Aug. 9, 2013 - Marketwire
University of Miami's Sylvester Comprehensive Cancer Center Announces Participation in DARA BioSciences Breast Cancer Patients for CAPTURE Registry 7:01 a.m. July 17, 2013 - Marketwire
DARA BioSciences Grants T3D Therapeutics Exclusive Worldwide Rights to Develop and Commercialize DB959 7:03 a.m. June 18, 2013 - Marketwire
DARA Biosciences Enrolls Leading Oncology Centers in Breast Cancer Patient Registry 6:32 a.m. June 3, 2013 - Marketwire
DARA Reports First Quarter 2013 Financial Results and Operational Highlights 3:50 p.m. May 15, 2013 - Marketwire
DARA and HELSINN Announce U.S. Launch of Gelclair(R), an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis 7:31 a.m. April 22, 2013 - Marketwire
DARA BioSciences Enters Into Distribution Agreement for Gelclair(R) and Soltamox(R) With Prime Therapeutics Specialty Pharmacy 7:03 a.m. April 3, 2013 - Marketwire

